ホーム>>Isotope-Labeled Compounds>> Deuterium>>(±)-CP 47,497-C8-homolog-d7 (exempt preparation)

(±)-CP 47,497-C8-homolog-d7 (exempt preparation) (Synonyms: Cannabicyclohexanold7)

カタログ番号GC48717

Products are for research use only. Not for human use. We do not sell to patients.

(±)-CP 47,497-C8-homolog-d7 (exempt preparation) 化学構造

サイズ 価格 在庫数 個数
100µg
$188.00
在庫あり
500µg
$754.00
在庫あり
1mg
$1,131.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(±)-CP 47,497-C8-homolog-d7 (exempt preparation) contains seven deuterium atoms at the 6, 6', 7, 7', 8, 8, and 8 positions. It is intended for use as an internal standard for the quantification of (±)-CP 47,497-C8-homolog (exempt preparation) by GC- or LC-mass spectrometry (MS). (±)-CP 47,497-C8-homolog is a bicyclic cannabinoid (CB) analog that avidly binds the CB1 receptor (Ki = 0.83 nM) and shows high antinociceptive activity.1 It is ten-fold more potent than δ9-tetrahydrocannabinol in analgesic, motor depressant, anticonvulsant, and hypothermic effects in mice.2

1.Melvin, L.S., Milne, G.M., Johnson, M.R., et al.Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogsMol. Pharmacol.44(5)1008-1015(1993) 2.Compton, D.R., Johnson, M.R., Melvin, L.S., et al.Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agentsJ. Pharmacol. Exp. Ther.260(1)201-209(1992)

レビュー

Review for (±)-CP 47,497-C8-homolog-d7 (exempt preparation)

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)-CP 47,497-C8-homolog-d7 (exempt preparation)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.